Results 21 to 30 of about 17,657 (165)

Effect of Garlic on Vancomycin-Resistant Enterococci [PDF]

Antimicrobial Agents and Chemotherapy, 1999
There is great concern about the worldwide increase in antibiotic resistance, especially of gram-positive bacteria such as vancomycin-resistant enterococci (VRE). As garlic, especially the thiosulfinate allicin, has been known for its antibacterial activity against facultative aerobic bacteria (2), the antibacterial effect of garlic alone and in ...
Jonkers, D, Sluimer, J, Stobberingh, E
openaire   +3 more sources

Vancomycin-resistant enterococci [PDF]

Acta clinica Croatica, 1999
Vancomycin-resistant enterococci (VRE) became nosocomial pathogens in the '90s. The increase in the incidence of infection and colonization with VRE poses a great problem, including the lack of available antimicrobial therapy for VRE infections, and possibility of transfer of the vancomycin-resistant genes present in VRE to other gram-negatiave ...
Jajić-Benčić, Ines, Benčić, Ivan.
  +5 more sources

First case of vanA-positive Enterococcus mundtii in human urinary tract infection in Iran

New Microbes and New Infections, 2016
We cultured enterococci from urinary tract infections in Iranian hospitals. Seven different Enterococcus species (E. raffinosus, E. durans, E. hirae, E. avium, E. mundtii, E. faecium and E. faecalis) were found.
M. Sharifi-Rad, S. Shadanpour, A. van Belkum, A. Soltani, J. Sharifi-Rad   +4 more
doaj   +1 more source

Revisiting Nitrofurantoin for Vancomycin Resistant Enterococci [PDF]

Journal of Clinical and Diagnostic Research, 2017
Introduction: Enterococcal infection has emerged as a major therapeutic challenge. Emergence of High Level Aminoglycoside Resistance (HLAR) and Vancomycin-Resistant Enterococcus (VRE) has further limited the drug therapy in enterococcal infections ...
Suneeta Meena, Sarita Mohapatra, Seema Sood, Benu Dhawan, Bimal Ku Das, Arti Kapil   +5 more
doaj   +1 more source

First detection of vanB phenotype-vanA genotype vancomycin-resistant enterococci in Egypt

Journal of Infection in Developing Countries, 2019
Introduction: Enterococci have emerged in last two decades as serious hospital acquired pathogens particularly vancomycin resistant strains (VRE).
Rasha MM Khairy, Mahmoud Shokry Mahmoud, Mona Abdel Monem Esmail, Aya Nabil Gamil   +3 more
doaj   +1 more source

Antibacterial resistance of Enterococcus spp. isolated from commercial poultry of the Russian Federation farms in 2013–2016, and identification of vancomycin resistance genes

Alʹmanah Kliničeskoj Mediciny, 2017
Rationale: Enterococci are the leading cause of a number of nosocomial and community-acquired human diseases. In the last decade, these pathogens are becoming resistant to antibacterials, including vancomycin.
E. A. Svetoch, M. G. Teymurazov, O. I. Tazina, A. A. Abaimova, A. I. Lev, E. I. Astashkin, E. S. Leonova, N. N. Kartsev, K. V. Detushev, B. V. Eruslanov, I. A. Dyatlov, N. K. Fursova   +11 more
doaj   +1 more source

Nosocomial Infection with Vancomycin-dependent Enterococci

Emerging Infectious Diseases, 2004
We report three patients infected with unique strains of vancomycin-dependent enterococci. Two were first infected by genetically identical strains of vancomycin-resistant enterococci (VRE).
Paul A. Tambyah, John A. Marx, Dennis G. Maki   +2 more
doaj   +1 more source

Iterative Chemical Engineering of Vancomycin Leads to Novel Vancomycin Analogs With a High in Vitro Therapeutic Index

Frontiers in Microbiology, 2018
Vancomycin is a glycopeptide antibiotic that inhibits transpeptidation during cell wall synthesis by binding to the D-Ala-D-Ala termini of lipid II. For long, it has been used as a last resort antibiotic.
Nigam M. Mishra, Izabela Stolarzewicz, Izabela Stolarzewicz, David Cannaerts, Joris Schuermans, Rob Lavigne, Yannick Looz, Bart Landuyt, Liliane Schoofs, Dominique Schols, Jan Paeshuyse, Peter Hickenbotham, Martha Clokie, Walter Luyten, Walter Luyten, Erik V. Van der Eycken, Erik V. Van der Eycken, Yves Briers, Yves Briers   +18 more
doaj   +1 more source

PREVALENCE OF LINEZOLID-RESISTANT VANCOMYCIN-RESISTANT ENTEROCOCCUS SPECIES (LRVRE) IN CLINICAL ISOLATES FROM TERTIARY CARE HOSPITAL OF NORTH INDIA – A REAL THREAT

International Journal of Infectious Diseases, 2023
Intro: Linezolid, an oxazolidinone antibiotic, was introduced early in 2000 as a new therapeutic option against gram positive cocci including vancomycin resistant enterococci (VRE).
S. Jain
doaj   +1 more source

Vancomycin-Resistant Enterococci

Postgraduate medicine
Preview New antimicrobial pathogens resistant to vancomycin are wreaking havoc in medical centers throughout the nation. Their tendency to colonize or infect severely ill, hospitalized patients who have undergone invasive procedures and received prolonged courses of antimicrobial therapy is alarming.
Levitus M, Rewane A, Perera TB.
europepmc   +2 more sources